Skip to content
OpenCapital
Get started

Evolus EOLS Market capitalization

Market capitalization at other companies

AbbVie logo
AbbVieABBV
$384.69B+3.8%

Other financials

Income statement

See full
Revenue$73.1M+6.7%
Gross profit$48.9M+4.8%
Operating income-$6.8M+54.9%
Net income-$10.7M+43.5%
EPS (diluted)-$0.16+46.7%

Balance sheet

See full
Cash & equivalents$49.8M-26.7%
Total debt$164.9M-4.1%
Total equity-$28.8M-336%
Total assets$220.6M+3.4%

Cash flow

See full
Operating cash flow-$10.0M+36.3%
CapEx$415.0K+30.1%
Free cash flow-$10.4M+35.0%

Valuation

See full
Enterprise value$585.97M-16.6%
P/S1.6×-0.6×

Profitability

See full
Gross margin66.1%-2.4pp
Operating margin-13.7%-1.9pp
Net margin-14.4%-3.3pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×—
Current ratio2×-0.3×

Where this comes from

Computed from the period-end share price: $267.4M.

The official record: Evolus’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolus's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolus's market capitalization?
Evolus (EOLS) reported market capitalization of $267.4M in Q1 2026.
How has Evolus's market capitalization changed year-over-year?
Evolus's market capitalization decreased by 65.0% year-over-year, from $764.95M to $267.4M.
What is the long-term trend for Evolus's market capitalization?
Over 5 years (2020 to 2025), Evolus's market capitalization has grown at a 18.2% compound annual growth rate (CAGR), from $186.74M to $431.05M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.